Open Source Platform for Transperineal In-Bore MRI-Guided Targeted Prostate Biopsy

被引:1
作者
Herz, Christian [1 ]
Tuncali, Kemal [1 ]
Fedorov, Andriy [1 ]
MacNeil, Kyle [2 ]
Behringer, Peter A. [1 ]
Tokuda, Junichi [1 ]
Mehrtash, Alireza [1 ]
Mousavi, Parvin [2 ]
Kikinis, Ron [1 ]
Fennessy, Fiona M. [1 ]
Tempany, Clare M. [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Queens Univ, Kingston, ON, Canada
基金
美国国家卫生研究院;
关键词
Biopsy; Software; Needles; Tools; Glands; Three-dimensional displays; Image segmentation; Image-guided interventions; image registration; magnetic resonance imaging; prostate cancer; software evaluation; targeted biopsy; IMAGE REGISTRATION; ULTRASOUND FUSION; CANCER; SOFTWARE; STATE;
D O I
10.1109/TBME.2019.2918731
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: Accurate biopsy sampling of the suspected lesions is critical for the diagnosis and clinical management of prostate cancer. Transperineal in-bore MRI-guided prostate biopsy (tpMRgBx) is a targeted biopsy technique that was shown to be safe, efficient, and accurate. Our goal was to develop an open source software platform to support evaluation, refinement, and translation of this biopsy approach. Methods: We developed SliceTracker, a 3D Slicer extension to support tpMRgBx. We followed modular design of the implementation to enable customization of the interface and interchange of image segmentation and registration components to assess their effect on the processing time, precision, and accuracy of the biopsy needle placement. The platform and supporting documentation were developed to enable the use of software by an operator with minimal technical training to facilitate translation. Retrospective evaluation studied registration accuracy, effect of the prostate segmentation approach, and re-identification time of biopsy targets. Prospective evaluation focused on the total procedure time and biopsy targeting error (BTE). Results: Evaluation utilized data from 73 retrospective and ten prospective tpMRgBx cases. Mean landmark registration error for retrospective evaluation was 1.88 & x00B1; 2.63 mm, and was not sensitive to the approach used for prostate gland segmentation. Prospectively, we observed target re-identification time of 4.60 & x00B1; 2.40 min and BTE of 2.40 & x00B1; 0.98 mm. Conclusion: SliceTracker is modular and extensible open source platform for supporting image processing aspects of the tpMRgBx procedure. It has been successfully utilized to support clinical research procedures at our site.
引用
收藏
页码:565 / 576
页数:12
相关论文
共 50 条
  • [21] Comparison between "In-bore" MRI guided prostate biopsy and standard ultrasound guided biopsy in the patient with suspicious prostate cancer: Preliminary results
    D'Agostino, Daniele
    Bianchi, Federico Mineo
    Romagnoli, Daniele
    Corsi, Paolo
    Giampaoli, Marco
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Artibani, Walter
    Porreca, Angelo
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2019, 91 (02) : 87 - 92
  • [22] MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature
    Pokorny, Morgan
    Kua, Boon
    Esler, Rachel
    Yaxley, John
    Samaratunga, Hemamali
    Dunglison, Nigel
    Gianduzzo, Troy
    Coughlin, Geoff
    Holt, Ross
    Laing, Barbara
    Ault, Darren
    Brown, Nicholas
    Parkinson, Rob
    Thompson, Les
    WORLD JOURNAL OF UROLOGY, 2019, 37 (07) : 1263 - 1279
  • [23] In-bore MRI targeted biopsy. Lights and shadows
    Creti, Totaro A.
    Ragonese, Mauro
    UROLOGIA JOURNAL, 2024, 91 (03) : 457 - 458
  • [24] In-bore MR prostate biopsy - initial experience
    Rembak-Szynkiewicz, Justyna
    Wojcieszek, Piotr
    Hebda, Anna
    Mazgaj, Patrycja
    Badzinski, Arkadiusz
    Stasik-Pres, Gabriela
    Chmielik, Ewa
    Bobek-Billewicz, Barbara
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (04) : 712 - 724
  • [25] Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard
    Schimmoeller, L.
    Quentin, M.
    Arsov, C.
    Lanzman, R. S.
    Hiester, A.
    Rabenalt, R.
    Antoch, G.
    Albers, P.
    Blondin, D.
    EUROPEAN RADIOLOGY, 2013, 23 (11) : 3185 - 3190
  • [26] Transperineal In-Bore 3-T MR Imaging-guided Prostate Biopsy: A Prospective Clinical Observational Study
    Penzkofer, Tobias
    Tuncali, Kemal
    Fedorov, Andriy
    Song, Sang-Eun
    Tokuda, Junichi
    Fennessy, Fiona M.
    Vangel, Mark G.
    Kibel, Adam S.
    Mulkern, Robert V.
    Wells, William M.
    Hata, Nobuhiko
    Tempany, Clare M. C.
    RADIOLOGY, 2015, 274 (01) : 170 - 180
  • [27] A system for MRI-guided transperineal delivery of needles to the prostate for focal therapy
    Cepek, Jeremy
    Chronik, Blaine A.
    Lindner, Uri
    Trachtenberg, John
    Davidson, Sean R. H.
    Bax, Jeffrey
    Fenster, Aaron
    MEDICAL PHYSICS, 2013, 40 (01)
  • [28] Accuracy analysis in MRI-guided robotic prostate biopsy
    Xu, Helen
    Lasso, Andras
    Guion, Peter
    Krieger, Axel
    Kaushal, Aradhana
    Singh, Anurag K.
    Pinto, Peter A.
    Coleman, Jonathan
    Grubb, Robert L., III
    Lattouf, Jean-Baptiste
    Menard, Cynthia
    Whitcomb, Louis L.
    Fichtinger, Gabor
    INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY, 2013, 8 (06) : 937 - 944
  • [29] Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
    Schimmoeller, L.
    Quentin, M.
    Blondin, D.
    Dietzel, F.
    Hiester, A.
    Schleich, C.
    Thomas, C.
    Rabenalt, R.
    Gabbert, H. E.
    Albers, P.
    Antoch, G.
    Arsov, C.
    EUROPEAN RADIOLOGY, 2016, 26 (11) : 3858 - 3864
  • [30] The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy
    Mert Kilic
    Serdar Madendere
    Metin Vural
    Ersin Koseoglu
    Mevlana Derya Balbay
    Tarik Esen
    World Journal of Urology, 2023, 41 : 449 - 454